期刊文献+

大鼠和家犬体内加替沙星的测定及药物动力学的研究 被引量:5

Pharmacokinetics and tissues distribution of Gatifloxacin in rats and dogs by HPLC
下载PDF
导出
摘要 目的采用HPLC测定加替沙星在犬和大鼠各组织中的浓度并研究其体内过程。方法家犬po5、10、20mg·kg^-1加替沙星后,测定不同时间血清中浓度,计算药动学参数。大鼠po20mg·kg^-1加替沙星后,测定各组织的药物浓度,并测定尿液、胆汁与粪便累积排泄率。结果加替沙星的犬药动学符合一室模型,AUC0~24和Cmax与剂量平行,Tmax与剂量无关。大鼠po加替沙星后快速分布在各组织中,其中肝、肾、小肠、胃分布最多,大脑未检测到药物。48h后,尿液、胆汁与粪便中的药物累积排泄率分别为66.2%±8.8%、8.05%±3.08%和3.63%±1.65%。结论加替沙星口服吸收快,消除半衰期长,组织分布广。 OBJECTIVE To establish an HPLC method for determination of Gatifloxacin in vivo course of rats and dogs.METHODS Following administration of a single of 5,10 and 20 mg·kg^-1 Gatifloxacin to dogs, the concentration of Gatifloxacin in intraverouy blood from 0.25 h to 24 h were examined by HPLC. And then the pharmacokinetic parameters were calculated. After a single of 20 mg·kg^-1 Gatifloxacin to rats, tissues of drug concentrations at 5 , 15 min and 4 h were determined. The urinary, bile and dejection accumulative excretions were determined. RESULTS The pharmacokinetic process of dogs fitted one corupartment model. AUC0-24 and Cmax were in proportion to the dosage while Tmax was in dependent of the dosage. After a single of 20 mg·kg^- 1 Gatifloxacin to rats, drug was rapidly and extensively distributed to all tissues at 5min, 15min and 4 h, especially in liver, intestines, stomach and kidney. No Gatifloxacin was determined in brain. The accumulative exaction in urine, bile and dejection in rats were 66.2%±8.8%, 8.05 %±3.08% and 3.63 %±1.65 %, respectivelly. CONCLUSION Gatifloxacin is rapidly absorbed with a longer haft life and abroad distribution. Understanding in vivo course of Gatifloxacin will offer the reference for the clinical application.
出处 《华西药学杂志》 CAS CSCD 北大核心 2006年第1期32-35,共4页 West China Journal of Pharmaceutical Sciences
基金 广西自然科学基金资助(编号:0249016)
关键词 加替沙星 体内过程分析 药物动力学 反相高效液相法 Gatifloxacin In vivo course Pharmacokinetics RP - HPLC
  • 相关文献

参考文献6

二级参考文献10

  • 1[1]Perry-CM,Barman-Balfour-JA,Lamb-HM,et al.Gatifloxacin[J]. Drugs,1999,58(4):683. 被引量:1
  • 2Lubasch A, Keller I, Borner K,et al. Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin and moxifloxacin after single oral administration in healthy volunteers.J Anthmicrob Agents Chemother,2000,44(10) :2600 被引量:1
  • 3Naber CK, Steghafner M, Kingig-Schippers M, et al. Concentrations of gatifloxacin mesylate in plasma and urine and penetrition into prostatic and seminal fluid,ejaculate,and sperm cells after single oral administrations of 400 milligrams to volunteers. J Anthmicrob Agents Chemother,2001,45 (1) :293 被引量:1
  • 4Nakashima M, Uematsu T, Kosuge K,et al. Single - and multiple -dose pharmacokinetics of AM - 1155, a new 6 - fluoro - 8 - methoxy quinolone, in humans. J Antimicrob Agents Chemother, 1995, 39(12) :2635 被引量:1
  • 5Stahlberg H J, Gohler K, Guillane M,et al. Effects of gatifloxacin mesylate ( GTFX ) on the pharmacokinetics of theophyline in heathly young volunteers [ abstract]. J Antimicrob Agents Chemther, 1999,44(suppl A) :136 被引量:1
  • 6Perry CM, Balfour JAB, Lamb HM. Gatifloxacin. Drugs, 1999, 58(4) :683 被引量:1
  • 7Hosaka M,Yasue T,Fukuda H,et al. In vitro and in vivo antibacterial activities of AM - 1155, a new 6 - fluoro - 8 - methoxy quinolone. J Antimicrob Agents Chemother, 1992,36 ( l0 ) :2108 被引量:1
  • 8孙涛,宋坤改,林赴田.盐酸加替沙星的药代动力学研究[J].中国新药杂志,2000,9(11):758-761. 被引量:35
  • 9周伟澄,张秀平.氟喹诺酮药物研究新进展[J].中国新药杂志,2000,9(10):667-670. 被引量:62
  • 10邓立东,程强,徐勤.HPLC法测定加替沙星血药浓度[J].华夏医学,2002,15(2):159-160. 被引量:6

共引文献55

同被引文献19

引证文献5

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部